Clinical Trials Directory

Trials / Completed

CompletedNCT05895071

Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts

Comparative Efficacy of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Combined Military Hospital Abbottabad · Academic / Other
Sex
All
Age
4 Years – 30 Years
Healthy volunteers
Not accepted

Summary

ABSTRACT Objective: To study the efficacy while comparing Potassium hydroxide 5% with liquid nitrogen in treatment of plane warts. Study design: Randomized-controlled trial (RCT), (Double-blind). Study setting and duration: Dept dermatology, CMH-Abbottabad, Nov-2022 / April-2023. Methodology: The sample size of 60 patients (children and adults aged 4 to 30 years) was calculated using Openepi app sample size RCT calculator, after informed consent by using non-probability consecutive sampling technique. Patients randomly assigned into two groups i.e. In group-A 30 patients were given topical 5%-potassium hydroxide solution on affected area once at night upto 4 weeks and in group-B 30 patients treated with cotton bud method of cryotherapy with liquid nitrogen once every two weeks. Patients were reassessed at every two weeks and final assessment was done at 12th week whereas followed up for 3 months to monitor recurrence. Demographic information and frequency percentages were calculated for qualitative variables by using SPSS26. To determine statistical significance taking p-value \<0.05 as significant, and χ2-square test was used.

Conditions

Interventions

TypeNameDescription
DRUG5%potassium hydroxide. In group-A 30 patients were given topical 5% potassium hydroxide solution on affected area once at night for upto 4 weeks
DRUGLiquid nitrogenin group-B 30 patients treated with cotton bud method of cryotherapy with liquid nitrogen once every two weeks. Patients were reassessed at every two weeks. The treatment carried out upto 12 weeks or until complete recovery from warts.

Timeline

Start date
2022-11-01
Primary completion
2023-04-30
Completion
2023-04-30
First posted
2023-06-08
Last updated
2023-06-08

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05895071. Inclusion in this directory is not an endorsement.